(0.24%) 5 112.39 points
(0.21%) 38 320 points
(0.24%) 15 966 points
(-1.42%) $82.66
(3.85%) $1.997
(0.03%) $2 347.80
(0.01%) $27.54
(3.53%) $954.65
(-0.19%) $0.933
(-0.32%) $10.99
(-0.44%) $0.797
(1.49%) $93.24
@ $0.370
Issued: 9 Feb 2024 @ 09:30
Return: 43.88%
Previous signal: Feb 8 - 14:29
Previous signal:
Return: -6.68 %
Live Chart Being Loaded With Signals
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases...
Stats | |
---|---|
Today's Volume | 27 006.00 |
Average Volume | 1.01M |
Market Cap | 36.39M |
EPS | $0 ( 2024-04-04 ) |
Next earnings date | ( $-0.0700 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.330 |
ATR14 | $0.00800 (1.50%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Lebovits Chaim | Buy | 15 000 | Common Stock |
2024-04-17 | Dagher Ibrahim B. | Buy | 0 | Common Stock |
2024-04-17 | Dagher Ibrahim B. | Sell | 0 | Common Stock |
2024-04-17 | Dagher Ibrahim B. | Buy | 0 | Common Stock |
2024-04-18 | Lebovits Chaim | Buy | 115 072 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 89 transactions |
Buy: 3 045 109 | Sell: 254 714 |
Volume Correlation
Brainstorm Cell Correlation
10 Most Negative Correlations | |
---|---|
CYRN | -0.828 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Brainstorm Cell Correlation - Currency/Commodity
Brainstorm Cell Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-265 000 (0.00 %) |
EPS: | $-0.400 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-265 000 (0.00 %) |
EPS: | $-0.400 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-285 000 (0.00 %) |
EPS: | $-0.650 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Brainstorm Cell
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators